Correction to: Phase I study of the antiTIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors.
Cancer Chemother Pharmacol
; 2024 Mar 31.
Article
in En
| MEDLINE
| ID: mdl-38556530
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2024
Document type:
Article
Affiliation country:
Japan